▲ +125.08% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Fennec Pharmaceuticals in the last 3 months. The average price target is $14.00, with a high forecast of $18.00 and a low forecast of $11.00. The average price target represents a 125.08% upside from the last price of $6.22.
The current consensus among 4 contributing investment analysts is to buy stock in Fennec Pharmaceuticals. This Buy consensus rating has held steady for over two years.